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Abstract
Background: Maule Cohort (MAUCO), a Chilean cohort study, seeks to analyze the natural history of chronic diseases
in the agricultural county of Molina (40,000 inhabitants) in the Maule Region, Chile. Molina´s population is of particular
interest because in the last few decades it changed from being undernourished to suffering excess caloric intake, and
it currently has the highest national rates of cardiovascular diseases, stomach cancer and gallbladder cancer. Between
2009 and 2011 Molina´s poverty rate dropped from 24.1 % to 13.5 % (national average 20.4 %); in this period the
county went from insufficient to almost complete basic sanitation. Despite these advances, chemical pollutants in the
food and air are increasing. Thus, in Molina risk factors typical of both under-developed and developed countries
coexist, generating a unique profile associated with inflammation, oxidative stress and chronic diseases.
Methods/Design: MAUCO is the core project of the recently established Advanced Center for Chronic Diseases
(ACCDiS), Universidad de Chile & Pontificia Universidad Católica de Chile. In this study, we are enrolling and following
10,000 adults aged 38 to 74 years over 10 years. All eligible Molina residents will be enrolled. Participants were
identified through a household census. Consenting individuals answer an epidemiological survey exploring risk factors
(psycho-social, pesticides, diet, alcohol, and physical activity), medical history and physical and cognitive conditions;
provide fasting blood, urine, and saliva samples; receive an electrocardiogram, abdominal ultrasound and bio-impedance
test; and take a hand-grip strength test. These subjects will be re-interviewed after 2, 5 and 7 years. Active surveillance of
health events is in place throughout the regional healthcare system. The MAUCO Bio-Bank will store 30 to 50 aliquots per
subject using an NIH/NCI biorepository system for secure and anonymous linkage of samples with data.
Discussion: MAUCO´s results will help design public health interventions tailored to agricultural populations in Latin
America.
Keywords: Prospective studies, Cohort studies, Population surveillance, Chronic disease/epidemiology, Agricultural
workers diseases, Cardiovascular diseases, Neoplasms/Epidemiology
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Background
In just 40 years, the Chilean population experienced
major socio-environmental changes associated with sig-
nificant shifts in its health profile. Between 1970 and
2010, life expectancy increased from 64.7 to 81.3 among
women and from 58.5 to 75.8 years among men. On
average, life expectancy increased by 7 months per year
between 1970 and 1990, and 3 months per year between
1990 and 2010 [1]. Unfortunately, for most of the popu-
lation these additional years are affected by chronic
diseases (CDs). Cross-sectional health surveys of the
Chilean population in 2003 [2] and 2009 [3] revealed
high and generally increasing prevalence of CDs and
their risk factors: hypertension (32.3 % and 29.2 % in
2003 and 2009, respectively), diabetes (6.3% and 9.4%),
high risk of cardiovascular disease on the Framingham
score (14.0 % and 17.7 %), overweight (37.8% and 39.3 %),
obesity (23.2 % and 25.1 %), high cholesterol (35.4 % and
38.5 %) and tobacco consumption (42.0 % and 41.0 %).
Given that the prevalence of risk factors is still increasing,
the peak of CD burden is yet to come.
In contrast to the health transition of most developed
countries, in Chile the increase in life expectancy occurred
before most of the population achieved socioeconomic
development. In fact, a large proportion of the population
is still living in poverty (20.4 %) [4]. The increase in popu-
lation survival is the result of the high coverage of
maternal and child healthcare, immunization and food
supplementation programs, and a decline in fertility rates
[5]. Simultaneously, a centralized national sanitation pol-
icy secured clean drinking water for the whole country.
Even though coverage of safe drinking water grew rapidly
in the 1970s and reached 97 % of population by 1990,
there was virtually no wastewater treatment in 1990. Thus,
while people drank clean water, they ate food that was irri-
gated with highly contaminated wastewater [6]. Since
then, coverage increased substantially and currently
includes 98% of the population [7]. Besides sanitation, very
little has been done to control pesticides and chemicals in
food throughout the country. Similarly, air pollution is
increasing rapidly in large and small cities, and in the
latter is largely, but not exclusively, associated with wood-
based heating. The Chilean regulatory system is more
permissive than the WHO guidelines [8, 9]. Thus, in
Chile, risk factors for CD development cohabitate with the
remains of underdevelopment [5], including a high burden
of chronic infections (H. pylori >73 %) [10], together with
high rates of obesity [3]. Little is known about the natural
history of CDs in this particular socio-environmental
context, and it remains unclear which are the most appro-
priate health risk indicators and/or prevention strategies.
The general objectives of the study are: i) To analyze
the natural history of CDs in a high risk population by
measuring the prevalence and evolution of CDs and
their risk factors. The health outcomes of interest
include: cardiovascular disease, metabolic syndrome,
cancer, obesity, aging, mental health, quality of life, oral
health and respiratory diseases. The risk factors of inter-
est include: socio-economic, occupational, psychological,
lifestyle (diet, physical activity, tobacco, and alcohol con-
sumption), environmental, genetic and ethnic exposures.
ii) To build a capacity to develop advanced epidemio-
logical, clinical and basic research in CDs in Chile and
specifically to create Data-Bank and Bio-Banks with an
appropriate infrastructure to facilitate access to the data
and samples for studies that address relevant research
questions.
Our aim is to establish the first Chilean population
cohort of CDs in the town of Molina in the Maule
region, the Maule Cohort (MAUCO). This region in
Central Chile has the highest standardized national
mortality rates (SMR) for CDs [11], with 46.5 % of the
population residing in the highest quintile of mortality
for cardiovascular disease and 61 % for cerebrovascular
ischemic disease [11], as well as the highest incidence
of stomach cancer [10, 12]. Within the Maule region,
Molina County has the highest SMR due to diabetes,
dementia, Alzheimer’s disease, cardiovascular diseases
and pneumonia. Males have excessively increased risk
of mortality due to cirrhosis, stomach and prostatic
cancer and heart ischemic illnesses, while woman are
afflicted by gallbladder cancer, hypertension and non-
ischemic heart diseases [13]. We hypothesize that com-
mon environmental factors are at the origin of these
chronic conditions possibly causing chronic inflamma-
tion and oxidative stress.
MAUCO is the core project of the new Advanced
Center for Chronic Diseases (ACCDiS), supported by the
Fund for Research Centers in Priority Areas Program
(FONDAP) of the Chilean National Commission for
Scientific and Technological Research (CONICYT).
MAUCO is initially funded for 10 years, and in this
period MAUCO will recruit 10,000 adults from the
general population and conduct follow-up visits.
Methods/Design
Study design and setting
MAUCO is a prospective population-based cohort study
of individuals aged 38 to 74 years.
The Maule Region is one of the 15 administrative
divisions of Chile, and the capital is Talca. This region
has a surface area of 20,600 km2 with 955,048 inhabi-
tants. Molina, one of its 30 counties, is 1,552 km2 in
size (599 sq. mi) and lies 200 km south of Santiago,
latitude -35.1165, longitude -71.2830 and altitude of
243 m above sea level [14]. Molina has 42,859 inhabi-
tants, 30.1 % living in rural areas and 50.2 % male. In
2009, the poverty rate was 24.1% (CI = 17.7-30.2 %),
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and it dropped to 13.5 % (CI = 9.3-17.3 %) in 2011,
representing a 40 % reduction in only 2 years. These
changes were largely due to agricultural modernization
and position Molina well above the national average
(24.3 % of population living in poverty in 2011) [4, 15].
In addition, 87 % of the Molina population benefit from
access to the public health system [16].
MAUCO’s organization
a) Directorate: The cohort has an Epidemiologist Director
(C.F.), an Executive Committee, comprised of the six
ACCDiS principal investigators (S.L., C.F., P.F.C, A.F.Q,
A.C., M.J.K.) and an Advisory Board. b) Advisory Board:
The Advisory Board includes representatives of the Minis-
try of Health, the Regional Health Service, the Funding
Agency, non-profit health organizations, Scientific Soci-
eties and representatives of the community. The Board
defines the criteria and the decision-making processes
regarding the use and sharing of data and samples. c) Field
team: The field team includes epidemiologists, nurses,
medical technologists, healthcare assistants and admin-
istrative clerks who 1) conduct the census, enrollment,
survey and examination of participants and 2) collect
samples, enter data and communicate with the commu-
nity. d) Health surveillance team: The surveillance team
is composed of clinicians, nurses, laboratory technolo-
gists and healthcare assistants, who actively search for
events affecting the cohort participants in any of the
region’s public hospitals. e) MAUCO epidemiologists and
data managers: Led by the MAUCO Director, this team is
responsible for the design, implementation, quality and
accuracy of the study, data synthesis and analysis.
Participants and selection criteria
All Molina residents aged 38 to 74 years are potentially
eligible. To be eligible, individuals must have resided in
Molina for at least 6 months of the past year and do not
plan to move from Molina within 3 years of enrollment.
Individuals who cannot give informed consent autono-
mously (e.g., cognitive impairment, dementia) or have a
terminal illness are excluded.
We identify the geographic distribution of eligible
residents through a household census, which records
their age and sex, as well as basic household data (water
and electricity provision, housing construction mate-
rials) and coordinates (latitude-longitude coordinate’s
format, WGS84). Google Maps and Open Street Maps
are used for geo-referencing. Based on census estimates
[16], we computed a target population of 14,000
individuals, with an expected response of 80 % partici-
pation at baseline (11,200), 90 % of which would be
finally eligible (10,800). Thus, the goal for enrollment
was set at 10,000 participants.
Recruitment
Individuals are contacted at their homes where the
objectives of the study are explained in a brochure and
the consent form. Accepting participants receive the first
interview and examination in their homes. This first
assessment consists of a 90 min health and risk factor
questionnaire validated for the Chilean population
(Table 1), physical condition evaluation, blood pressure
and heart rate measurements and cognitive tests
(Table 2). They are then appointed to the MAUCO
health-station, located alongside the public hospital of
Molina, to complete their baseline evaluation. At the
MAUCO health-station, fasting participants provide
urine, saliva and blood samples. Individuals also have
anthropometric measurements, bio-impedance analysis,
grip strength test, electrocardiogram (ECG), hepatobili-
ary ultrasonography, and oral examination (Table 2).
Participants receive the results of their baseline exams
(blood glucose, lipid and liver profile, blood pressure,
nutritional evaluation, electrocardiogram and hepatobili-
ary ultrasound) and medical advice if any abnormality
is detected, including reference to the emergency room
if needed.
Time line: enrollment and follow-up
Funding for the project was granted in December 2013
and field work began in July 2014 with the census and a
pilot project to develop strategies and instruments.
Enrollment, including bio-sampling, began in December
2014 and is expected to be completed by December
2016. Follow-up visits consist of a shorter version of the
baseline measurements to assess changes in exposure
and health conditions. This evaluation will also include
in-depth surveys of sub-groups, such us participants
exposed to pesticides or diagnosed with gallstones.
These visits will occur 2, 5 and 7 years after enrollment.
Surveillance of health events and expected events
To identify all health events affecting the cohort partici-
pants, in particular serious events requiring hospitalization,
we have established formal agreements with public hospi-
tals in the region where health events are likely to take
place. These agreements will permit us to link individuals
who are entering a hospital with the MAUCO database,
which will automatically send a report to the surveillance
team.
Based on Chilean cancer surveillance [15], regional
mortality and international incidence data, we expect
1,265 health events in the first 5 years of follow-up,
including 385 cases of new-onset diabetes mellitus, 309
cases of cancer, 120 cases of acute myocardial infarction,
115 cases of chronic pulmonary disease, 160 cardiovas-
cular events (cardiac failure and cerebral stroke) and
230 deaths.
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Table 1 Baseline questionnaire data collected in MAUCO 2014-2016
Factors Instruments
Quality of life and lifestyle General healtha; Tobacco, alcohol, medications, oral healthb
Cardiovascular diseases Medical historyb,c
Digestive diseases and cancer Personal and family medical history and symptomsd
Respiratory diseases Medical historyb
Mental health Depressione, medical history, cognitive statusf, Trail making
testg, stressh, instrumental activities of daily livingi.
Nutritional status Mediterranean dietj, cooking method of mealsk
Physical condition Physical activityd, sedentary behaviorl
Hearing and seeing status Medical historyb
Socio-cultural risks Socioeconomicb, social networksm, employment statusn
Environmental & work exposures Chemicals, pesticideso
Women’s reproductive health Hormonalb, reproductive, cervical and breast cancer screeningd.
aSF-12 Instrumental Activities of daily living questionnaire
bEncuestas Nacionales de Salud de Chile (ENS) (Chilean National Health Survey)
2009. http://www.dinta.cl/wp-dintacl/wp-content/uploads/Presentacion-ENSalud-2010.pdf
cMinnesota Living with Heart failure Questionnaire
dENS 2003. http://www.ine.es/metodologia/t15/t1530419.htm
ePatient Health Questionnaire PHQ-9
fAddenbrooke’s cognitive examination- Revised, Spanish version: Muñoz-Neira et al. 2012 Rev Med Chilehilee 2012;140:1006-1013
gReitan, C. (1992). The Trail Making Test: Manual for administration and scoring. Tucson: The Reitan Neuropsychological Laboratory
hLanas et al. Rev Med Chile 2007 136: 555-560
iMuñoz-Neira et al. 2012 Dement Geriatr Cogn Disord 2012;33:361–371
jLeighton et al. Public Health Nutrition. 2009; 12(9A), 1635–1643
kPLCO Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
lGPAQ- WHO Global Physical Activity Questionnaire
mSapaj et al. J Epidemiol Community Health. 2008;62(9):790–2
nEncuesta Nacional de Empleo, Trabajo, Calidad de Vida y Salud de los Trabajadores y Trabajadoras de Chile 2009-2010 (ENETS) (National Survey of Employment,
Labour, Quality of Life and Health of the Workers of Chile 2009-2010)
http://www.isl.gob.cl/wp-content/uploads/2011/10/PRESENTACION-ENETS-2009-2010-FINALINTERINSTITUCIONAL.pdf
oProspective Investigation of Pesticide Applicators’ Health Study (PIPAH)
Table 2 Baseline physical examinations, imaging studies and laboratory tests in MAUCO 2014-2016
Health condition examined Instruments & tests
Physical condition (frailty) Peak expiratory flow (PEF), handgrip strength, bio-impedance, self-reported waking speed, Up and Go test 2.5 m
Cardiovascular system Blood pressure and heart rate, electrocardiogram, blood lipids
Hepatobiliary system Hepatobiliary ultrasound, liver profile (blood GOT, GPT, bilirubin)
Diabetes Glycaemia
Pulmonary function Peak expiratory flow (PEF)
Cognitive function Attention, memory, language and executive functions. Activities of daily living.
Oral health Tooth count, oral examination for periodontal disease
Anthropometric
measurements
Height; weight; waist, hip, neck & ankle circumference; arm span
Basal inflammatory status Immunological panel in blooda
Infectious disease biomarkers for H. pyloria, S. typhia; microbiota characteristics in salivaa
Genetic determinants DNA biobanking for future genomic studies
Environmental exposure Aflatoxin biomarkers in urine and blooda, pesticides biomarkers in blood or urinea, metals in urinea, nitrates in urine
and watera.
aPlaned for the baseline assessment
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Follow-up and retention strategy
To improve participation rates and maintain high adher-
ence to study protocols over time, a comprehensive
retention strategy is being developed. The first qualita-
tive study explored motivations, beliefs and preferences
of MAUCO participants to adhere to the study. This
information is being integrated in the development of a
retention strategy under the principles of Community-
Based Participatory Research (CBPR) [17], which aims to
engage the Molina community as a partner in the study,
promoting a good understanding of study goals and local
ownership in the study by community members. This
will also contribute to the design and implementation of
locally appropriate initiatives oriented towards chronic
disease prevention.
Maule Cohort Bio-Bank
MAUCO biological samples are stored following the US
National Cancer Institute (NCI), Biobank Quality Con-
trol regulation [18]. Standard operating procedures are
in place to ensure the quality of the MAUCO biological
samples from collection to storage. From the MAUCO
station, samples are transported at 4 °C to the near-by
laboratory in the Molina hospital. Samples are processed
within 2 h, and 30 to 50 aliquots per subject are stored
at -80 °C in the MAUCO Bio-Bank at the Molina hos-
pital; these samples are periodically transferred to the
Central Bio-Bank in the Pathology Department of the
Pontificia Universidad Católica de Chile in Santiago for
long-term storage at -80 °C. Forms, samples, and
aliquots have unique barcodes that are linked to a
sample tracking system. An inventory system of bio-
logical samples is used to identify the location and avail-
able quantity of each aliquot by Biological Specimen
Inventory (BSI) software (www.bsisystems.com).
MAUCO Data Bank
The MAUCO information system ensures safe, complete
and accurate data flow including data collection, data
entry and generation of databases. Data collection,
supervised by the field coordinator, is conducted by
health technicians using printed questionnaires. Data
entry, supervised by the data-manager, is done locally
using two services for data entry and dataflow: REDCap™
(Research Electronic Data Capture) [19] and Process-
Maker® (http://www.processmaker.com). REDCap™ is a
secure, web-based application designed to support data
capture for research studies, while ProcessMaker® is the
study management system that facilitates processes and
procedures. The management databases system MySQL
(https://www.mysql.com) is used to connect the online
servers with double backup (cloud and local).
Data analysis plan
MAUCO’s Data-Bank (MDB) includes individuals` base-
line data, follow-up data, surveillance findings and the
results of any other measurement carried out as part of
a sub-study. The cohort study design allows for a broad
range of hypothesis to be tested longitudinally. Examples
of initial planned analyses include the association of CDs
with: 1) pesticides and mycotoxins, 2) labor fragility and
social and psychosocial factors and 3) inflammatory con-
ditions such as gallstones. Our hypothesis is that CDs
share risk factors leading to chronic inflammation and
oxidative stress as the common underlying mechanism
for the development of cancer, cardiovascular disease
and other chronic conditions [20–23].
Ethics
The study protocol was approved by ethics committees
at Pontificia Universidad Católica de Chile and the
Maule Regional Service of the Chilean Ministry of
Health. Eligible individuals are invited to voluntarily par-
ticipate in the study, and the consent form has to be
fully read and explained to the subjects. Participants´
privacy is protected throughout the study process. Indi-
viduals with abnormal results are informed and referred
to their health care system accordingly.
Regulation of access to data/biospecimens
The access to data and biospecimens is regulated by
the ACCDiS directorate in accordance with the local
Institutional Review Board authorization. The regula-
tory system was developed following the UK Centre
for Longitudinal Studies [24] protocol, and aim to
make the data and biospecimens available to other
researchers while ensuring that ethical and scientific
principles are fulfilled. All data requests must be
approved by the Advisory Board and a bilateral agree-
ment must be signed before sharing of data. Inter-
national data requests can be allowed following the
same algorithm, using data views. Access to the server
will not be granted.
Outreach/dissemination
Outreach is targeted to the Molina community to inform
study findings and promote participation over time. We
developed a MAUCO logo, typography and printed ma-
terial (color brochures or leaflets) with information
about the study and its field team and interviews and
short capsules for the local radios, TV and newspapers,
including the municipal newsletter and the Molina
hospital online newsletter. The MAUCO website is cur-
rently in its beta version. Broader dissemination has
mainly been channeled through regional and national
print media (newspapers, magazines) featuring news
reports and interviews.
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Main strengths and weaknesses of the study
Among the strengths we can mention that this study is
conducted in a county with a particularly high burden of
CDs and unique exposures, where all citizens aged 38 to
74 years are invited to participate. The county economy
is agriculture based, including large vineyards. Molina
inhabitants are widely exposed to pesticides, mycotoxins
and alcohol consumption, which make this study par-
ticularly well-suited for assessing the role of these envir-
onmental factors in the development of chronic diseases.
We expect 3,000 subjects will be agricultural workers. In
fact MAUCO is part of the WHO AGRICOH [25], an
agricultural cohort consortium, along with 27 other
cohorts from the rest of the world [26]. MAUCO is the
first population-based CD cohort in Chile of this magni-
tude, with such a broad spectrum of exposures and
health outcomes. A particular novelty is that MAUCO
was developed through the interdisciplinary collabor-
ation of epidemiologists with basic and clinical scientists.
Data and biological samples from the population study
will inform the basic and clinical scientists, while
insights from laboratory experiments will help generate
new, more specific hypotheses at the population level.
Researchers at ACCDiS are national and international
leaders in their areas and the MAUCO team has great
experience in large population-based studies.
Local and regional authorities’ and institutions
(Molina´s Municipality and Hospital, Maule Health
Service, Universidad Católica del Maule), CONICYT, and
the primary Grantee Universities (Universdad de Chile
and Pontificia Universidad Católica de Chile) are
highly committed to the project, securing sustainabil-
ity of the cohort.
This project has a 10-year institutional funding com-
mitment, with the possibility of re-applying for another
10-year period. Principal and associate investigators and
collaborators are applying for additional sources of
funding. As an example the US National Cancer
Institute of the National Institutes of Health has pro-
vided guidance and training to help establish the
MAUCO Bio-Bank and equipment to facilitate a sub-
cohort of individuals with gallstones.
The study’s main challenges are the lack of experience
in Chile with population-based prospective studies with
long-term products, requiring large amounts of re-
sources (financial, human, infrastructure) and complex
organization to secure sustainability and high quality.
Also, sample and data storage is a developing field in
Chile, MAUCO´s Bio-Bank is one of the first initiatives
of this magnitude. Another limitation is related to the
external validity of our findings. MAUCO represents
agricultural populations from small cities in Latin
America. Some results may not be applicable to resi-
dents of large urban areas.
Discussion
MAUCO will provide high quality data and biological
samples that will be a resource for national and inter-
national research. Prevalence and dynamics of risk
factors for CDs and their biomarkers will be measured
in a unique epidemiological setting thus far not consid-
ered in the large cohorts of developed countries. This
cohort is similar in aims to European cohorts, such as
each of the German National Cohorts [27] and LifeLines
Cohort Study & Biobank [28]. MAUCO is exploring a
broad range of exposures from genetics to environmen-
tal exposures and their impact on health status, quality
of life, aging and cognitive performance. After an 8-year
embargo to complete the baseline measurements, data
and samples will be available for the scientific community.
MAUCO will permit assessing the effect of common risk
factors and establishing the reference values in this
population, providing key data for the design of interven-
tions suitable for this group. Furthermore, MAUCO will
provide the strategies, methods and tools to conduct this
type of study in other populations with diverse epidemio-
logical settings.
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